Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Bayer Expects HealthCare Sales Of About EUR 20 Bln In 2014 - Quick Facts

German conglomerate Bayer AG (BAYRY.PK,BAYZF.PK) on Wednesday said it sees good perspectives for its businesses in the medium term.

At the "Meet Management" investor conference on Wednesday in Leverkusen, CEO Marijn Dekkers said, "In the life science areas - HealthCare and CropScience - we anticipate further increases in sales and margins through 2014."

The company expects sales of Bayer HealthCare to reach approximately 20 billion euros in 2014, while Bayer CropScience aims to raise sales to more than 8 billion euros.

Bayer added that its MaterialScience segment intends to further strengthen its leading position in the market and plans to achieve volume gains in excess of the rate of global GDP growth.

Dekkers added that the main reason for the optimistic outlook for HealthCare subgroup is its well-stocked development pipeline in Pharmaceuticals. "We believe four of our medicines in late-stage development have blockbuster potential. That means each of these products could achieve peak annual sales of EUR 1 billion or more," he added.

The company added that it aims to successfully commercialize the late-stage pharmaceutical pipeline and take advantage of business opportunities in the emerging markets.

Register
To receive FREE breaking news email alerts for Bayer AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.